Is bicarbonate buffer suitable as a dissolution medium?

被引:43
作者
Boni, Julia Elisabeth
Brickl, Rolf Stefan
Dressman, Jennifer
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Pharmaceut Res & Dev, Biberach, Germany
[2] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-6000 Frankfurt, Germany
关键词
D O I
10.1211/jpp.59.10.0007
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The objectives of this study were to compare two methods for the preparation of bicarbonate buffer, and to compare media prepared with bicarbonate buffer with commonly used biorelevant and pharmacopoeial media in terms of their suitability for dissolution testing. The various media were compared with regard to ease of preparation, robustness and reproducibility of composition. The dissolution of three formulations of a typical Biopharmaceutical Classification System Class 11 drug (BIXX) was compared in bicarbonate buffer, standard phosphate buffer, a biorelevant buffer (fasted-state simulating intestinal fluid, FaSSIF) and a modified FaSSIF prepared With bicarbonate buffer. The bicarbonate buffer used for dissolution testing was produced by supplying carbon dioxide to a saline solution (0.9% NaCl, to which 12 or 42 mmol NaOH had been added). The bicarbonate buffer had to be prepared in-situ, which proved to be time-consuming, and the pH stability of the bicarbonate buffer could only be maintained under constant CO2 supply. To minimize the mechanical stress caused by inflow and evaporation of gas, the carbon dioxide was supplied above the medium during the dissolution test. Despite taking these measures, use of bicarbonate buffer led to less reproducible dissolution results than the phosphate buffers commonly used to prepare compendial media and FaSSIF, with coefficient of variance values 1.5- to 5-times higher in bicarbonate buffer. It was concluded that although a bicarbonate buffer system would tie physiologically relevant for the fasted state in the small intestine, its suitability for dissolution testing is restricted by lack of practicability and poor reproducibility of results.
引用
收藏
页码:1375 / 1382
页数:8
相关论文
共 19 条
[1]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]
APPLICATIONS OF THE HENDERSON-HASSELBALCH EQUATION TO SINGLE AND MIXED BUFFER SOLUTIONS - WITH A NOTE ON CONSTANTS FOR BICARBONATE BUFFER AND EXAMPLES OF APPLICATIONS TO WARBURG MANOMETRIC STUDIES [J].
BIRMINGHAM, MK ;
ELLIOTT, KAC .
CANADIAN JOURNAL OF MEDICAL SCIENCES, 1952, 30 (05) :403-416
[3]
A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions [J].
Blanquet, S ;
Zeijdner, E ;
Beyssac, E ;
Meunier, JP ;
Denis, S ;
Havenaar, R ;
Alric, M .
PHARMACEUTICAL RESEARCH, 2004, 21 (04) :585-591
[4]
Bucher GR, 1944, J BIOL CHEM, V155, P305
[5]
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs [J].
Dressman, JB ;
Reppas, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S73-S80
[6]
Dissolution of pH responsive formulations in media resembling intestinal fluids:: bicarbonate versus phosphate buffers [J].
Fadda, HM ;
Basit, AW .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2005, 15 (04) :273-279
[7]
Flemstrom G, 1987, PHYSL GASTROINTESTIN, P1011
[8]
Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs [J].
Galia, E ;
Nicolaides, E ;
Hörter, D ;
Löbenberg, R ;
Reppas, C ;
Dressman, JB .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :698-705
[9]
GALIA E, 1999, THESIS JOHANN WOLFGA
[10]
Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies [J].
Kalantzi, L ;
Goumas, K ;
Kalioras, V ;
Abrahamsson, B ;
Dressman, JB ;
Reppas, C .
PHARMACEUTICAL RESEARCH, 2006, 23 (01) :165-176